Stock Scorecard
Stock Summary for Exelixis Inc (EXEL) - $42.52 as of 6/11/2025 3:52:36 PM EST
Total Score
16 out of 30
Safety Score
52 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for EXEL
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EXEL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EXEL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EXEL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EXEL (52 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for EXEL
Financial Details for EXEL
Company Overview |
|
|---|---|
| Ticker | EXEL |
| Company Name | Exelixis Inc |
| Country | USA |
| Description | Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California. |
| Sector Name | TRADE & SERVICES |
| Industry Name | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 8/12/2025 |
Stock Price History |
|
| Last Day Price | 42.52 |
| Price 4 Years Ago | 18.28 |
| Last Day Price Updated | 6/11/2025 3:52:36 PM EST |
| Last Day Volume | 3,187,335 |
| Average Daily Volume | 3,425,062 |
| 52-Week High | 48.85 |
| 52-Week Low | 21.36 |
| Last Price to 52 Week Low | 99.06% |
Valuation Measures |
|
| Trailing PE | 19.09 |
| Industry PE | 62.92 |
| Sector PE | 50.71 |
| 5-Year Average PE | 32.60 |
| Free Cash Flow Ratio | 63.46 |
| Industry Free Cash Flow Ratio | 38.69 |
| Sector Free Cash Flow Ratio | 61.61 |
| Current Ratio Most Recent Quarter | 3.50 |
| Total Cash Per Share | 0.67 |
| Book Value Per Share Most Recent Quarter | 7.75 |
| Price to Book Ratio | 5.49 |
| Industry Price to Book Ratio | 5.83 |
| Sector Price to Book Ratio | 11.01 |
| Price to Sales Ratio Twelve Trailing Months | 4.92 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.51 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.43 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 272,708,000 |
| Market Capitalization | 11,595,544,160 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.47% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 358.30% |
| Annual Earnings Growth | 150.89% |
| Reported EPS 12 Trailing Months | 2.17 |
| Reported EPS Past Year | 0.62 |
| Reported EPS Prior Year | 1.92 |
| Net Income Twelve Trailing Months | 643,566,000 |
| Net Income Past Year | 521,267,000 |
| Net Income Prior Year | 207,765,000 |
| Quarterly Revenue Growth YOY | 30.60% |
| 5-Year Revenue Growth | 17.51% |
| Operating Margin Twelve Trailing Months | 33.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 183,752,000 |
| Total Cash Past Year | 217,374,000 |
| Total Cash Prior Year | 262,994,000 |
| Net Cash Position Most Recent Quarter | 183,752,000 |
| Net Cash Position Past Year | 217,374,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 2,244,203,000 |
| Total Stockholder Equity Prior Year | 2,263,912,000 |
| Total Stockholder Equity Most Recent Quarter | 2,131,024,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 790,390,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.90 |
| Free Cash Flow Past Year | 633,786,000 |
| Free Cash Flow Prior Year | 170,355,000 |
Options |
|
| Put/Call Ratio | 0.06 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.05 |
| MACD Signal | 1.32 |
| 20-Day Bollinger Lower Band | 31.22 |
| 20-Day Bollinger Middle Band | 38.11 |
| 20-Day Bollinger Upper Band | 44.99 |
| Beta | 0.28 |
| RSI | 59.11 |
| 50-Day SMA | 32.58 |
| 150-Day SMA | 24.08 |
| 200-Day SMA | 23.02 |
System |
|
| Modified | 6/11/2025 11:38:51 PM EST |